跳至主要内容
临床试验/JPRN-UMIN000011101
JPRN-UMIN000011101尚未招募未知

The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan. - The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy.

Saitama Medical Center, Saitama Medical University0 个研究点目标入组 50 人开始时间: 2013年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) diabetic ketoacidosis, diabetic coma, type 1 diabetes 2) with severe liver dysfunction 3) severe infection, before and after surgery, severe trauma 4) end-stage renal failure during dialysis or severe renal dysfunction (CrCl under 30ml/min) 5) pregnant 6) patients with a history of hypersensitivity to any component of this drugs

研究者

发起方
Saitama Medical Center, Saitama Medical University

相似试验

The inhibitory effects of the DPP-4 inhibitor for... | 临床试验